Publications:

Loss of E-cadherin Enhances IGF1-IGF1R Pathway Activation and Sensitizes Breast Cancers to Anti-IGF1R/InsR Inhibitors.

Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research

Nagle, Alison M AM; Levine, Kevin M KM; Tasdemir, Nilgun N; Scott, Julie A JA; Burlbaugh, Kara K; Kehm, Justin J; Katz, Tiffany A TA; Boone, David N DN; Jacobsen, Britta M BM; Atkinson, Jennifer M JM; Oesterreich, Steffi S; Lee, Adrian V AV

Publication Date: 2018-10-15

Variant appearance in text: EGFR: D75=

PubMed Link: 29941485

Variant Present in the following documents:

• Main text

View BVdb publication page

Small molecule epigenetic screen identifies novel EZH2 and HDAC inhibitors that target glioblastoma brain tumor-initiating cells.

Oncotarget

Grinshtein, Natalie N; Rioseco, Constanza C CC; Marcellus, Richard R; Uehling, David D; Aman, Ahmed A; Lun, Xueqing X; Muto, Osamu O; Podmore, Lauren L; Lever, Jake J; Shen, Yaoqing Y; Blough, Michael D MD; Cairncross, Greg J GJ; Robbins, Stephen M SM; Jones, Steven J SJ; Marra, Marco A MA; Al-Awar, Rima R; Senger, Donna L DL; Kaplan, David R DR

Publication Date: 2016-09-13

Variant appearance in text: EGFR: D75=

PubMed Link: 27449082

Variant Present in the following documents:

• oncotarget-07-59360.pdf

View BVdb publication page

Oncogenic MUC1-C promotes tamoxifen resistance in human breast cancer.

Molecular Cancer Research : Mcr

Kharbanda, Akriti A; Rajabi, Hasan H; Jin, Caining C; Raina, Deepak D; Kufe, Donald D

Publication Date: 2013-07

Variant appearance in text: EGFR: D75=

PubMed Link: 23538857

Variant Present in the following documents:

• Main text

View BVdb publication page